Primary Care Physicians and Clinicians. XXX on behalf of the Upper Midwest Fistula First Coalition. Chronic Kidney Disease (CKD) Resources
|
|
|
- Charlene Griffith
- 6 years ago
- Views:
Transcription
1 August 10, 2007 To: From: RE: Primary Care Physicians and Clinicians XXX on behalf of the Upper Midwest Fistula First Coalition Chronic Kidney Disease (CKD) Resources Caring for patients with chronic kidney disease (CKD) is a great challenge for both primary care providers and nephrologists. This challenge increases when patients do not receive a timely referral to a nephrologist. This delayed referral leads to emergency dialysis with higher morbidity, mortality and excessive cost. Emergency dialysis limits the dialysis modality choice, endangers the ability to place a permanent vascular access prior to dialysis initiation, precludes psychological preparation of patients and family, and frequently necessitates hospitalization for a catastrophic complex illness. Early referral of chronic kidney disease patients offers many advantages. In addition to beginning the process of education and preparation for renal replacement therapy, benefits include: A diligent search may reveal a potentially reversible cause of renal failure. A number of measures may be implemented to preserve the remaining renal function, e.g., good control of blood pressure, glucose control in diabetics, nutritional guidance, and avoidance of nephrotoxic drugs. Upper extremity vessels may be preserved for placement of a native arteriovenous fistula, the most reliable type of vascular access. Treatment of anemia with erythropoietin may significantly improve life quality. Secondary hyperthyroidism may be treated with phosphate binders and calcitriol. Referral to a team consisting of a nephrologist, renal dietitian, dialysis nurse, social worker and financial counselor allows time to establish the best treatment modality for the patient, develop financial support if needed and to allay the fears of both patient and family. In order to assist you in identifying and treating chronic kidney disease in your patients, we are providing you two resources to use within your practice. The first resource is a pocket guide developed by the National Kidney Disease Outcomes Quality Initiative (KDOQI) of the National Kidney Foundation (NKF) and includes the Clinical Action Plan to assist you in developing an individualized CKD plan of care for your patients, and Clinical Interventions for Adults that will provide a summary of recommended interventions for patients with complications associated with CKD. The second resource is a wall chart that displays two algorithms, a CKD assessment algorithm that will assist you in identifying patients as having CKD, and a treatment algorithm that will assist you in developing a treatment plan for patients with CKD. These resources are also available to download electronically at We hope you will find this a useful tool in working with your patients who may need treatment or referral for their kidney disease. If you have any questions please feel free to contact YYY at XXX-XXX-XXXX.
2 GFR CALCULATION To calculate GFR, the MDRD Formula can be used for adults: Estimated GFR (ml/min/1.73 m2) = 186 (SCr ) (Age) (0.742 if female) (1.21 if African American) Or visit the National Kidney Foundation website to use calculator: Adapted from the National Kidney Foundation. KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. AM J Kidney Dis 39, 2002 (suppl 1).
3 Adapted from the National Kidney Foundation. KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. AM J Kidney Dis 39, 2002 (suppl 1) Distributed with permission by the Upper Midwest Fistula First Coalition
4 CKD Assessment Algorithm Identification, Treatment, and Referral Patient Office Visit Is patient at risk for CKD? Susceptability Direct Risk Factors Progressive Risk Factors -Age > 60 years -Diabetes -Systemic infections -High levels proteinuria -Family history of CKD -High blood pressure -Urinary tract infection -Malignant hypertension -Autoimmune diseases -Urinary stones -Poor glycemic control -Lower urin tract obstruction -Drug toxicity -Smoking -Hx acute renal failure -Exposure drugs/procedures Change Concept 1 STOP Perform routine screening for CKD for patients at increased risk *Serum creatnine to determine estimated GFR *Assessment of proteinuria *Urinalysis for presence of white & red blood cells Change Concept 2 Determine Stage of CKD Does patient have abnormal GFR > 3 months? Does patient have protein to creatinine ratio > 1.0 gm? Stage 1 GFR > 90 P:C > 1.0 x 2 Stage 2 GFR Stage 3 GFR Stage 4 GFR Stage 5 GFR < 15 Follow Up CKD Monitoring -Test patients at risk for CKD annually -Counsel patients at risk for CKD but found not to have CKD to reduce risk factors when possible. Begin CKD Treatment: Develop Clinical Action Plan Collaborate with nephrologist to develop action plan to include: *Evaluate and manage comorbid conditions (Primary care, all stages) *Slow the loss of kidney function (Co-management, all stages) *Prevent & treat cardiovascular disease (Primary care, all stages) *Prevent & treat complications of decreased kidney function (Co-management, all stages) *Prepare for kidney failure and replacement therapy (Nephrology, stage 4) *Replace kidney function (Nephrology, stage 5) Consult nephrology if action plan cannot be performed or carried out or when GFR < 60 Change Concept 3 Identify risks associated with CKD *Evaluate type of kidney disease *Evaluate complications of kidney disease: anemia, hypertension, malnutrition, bone disease, metabolic acidosis, congestive heart failure, hyperkalemia, edema determined to fluid overload, neuropathy *Evaluate risk for loss of kidney function *Evaluate comoribid conditions *Evaluate risk for cardiovascular disease Change Concept 4 Assess barriers to treatment adherence *Family and social support *Depression *Income & unemployment concerns *Stress and coping mechanisms *Perceptions of illness & treatment *Limited access to medications and/or care Change Concept 6 Review medication usage at follow-up visits *Evaluate for necessary dose adjustments based on level of kidney function *Evaluate for adverse effects of medications on kidney function (NSAIDs, IV contrast) *Evaluate for drug interactions *Counsel patient to avoid nephrotoxic drugs and IV contrast *Evaluate appropriateness for ARB/ACE inhibitor with diagnosis of hypertension *Evaluate need for therapeutic drug monitoring Change Concept 5 Consult/Refer to Nephrologist Monitor CKD Progression Does patient have GFR < 60 for > 3 months or proteinuria > 3 gm? *Consult nephrologist at Stage 1 if hematuris or significant proteinuria present *Consult nephrologist at Stage 2 if GFR declines > 4mL/min/yr *Consult nephrologist at Stage 3 for al patients with CKD *Refer patient to nephrologist for evaluation when GFR < 30 ml/min/ Change Concept 7
5 CKD Treatment Algorithm CKD Stage 1 GFR > 90 P:C ratio > 1.0 gm protein/gm creatinine x 2 CKD Stage 2 GFR CKD Stage 3 GFR CKD Stage 4 GFR CKD Stage 5 GFR < 15 PRIMARY CARE PRIMARY CARE CO-MANAGEMENT NEPHROLOGY NEPHROLOGY BP monitoring q 6 mo. GFR q 12 mo. Urinalysis q 12 mo. to assess hematuria, proteinuria, microalbuminuria BP monitoring q 3-12 mo. GFR q 12 mo. Urinalysis q 3-12 mo. to assess hematuria, proteinuria, microalbuminuria Lipids q 12 mo Hgb q 12 mo. if > 11 gm/dl Distributed by the Upper Midwest Fistula First Coalition BP monitoring q 3-12 mo. GFR q 3-12 mo. Urinalysis q 6-12 mon. to assess hematuria, proteinuria, microalbuminuria Lipids q 2 mo Hgb > 11 q 3-6 mo. Hgb < 11 q 1-3 mo. Lytes and glucose q 12 mon. PTH, Ca & P q 3-12 mo. salt & potassium The Kidney Disease Outcomes Quality Initiative (KDOQI) recommendations for Chronic Kidney Disease: Evaluation, Classification, and Stratification were used to develop portions of these documents. BP monitoring q 3-6 mo. GFR q 3-6 mo. Hgb q 3-6 mo., monthly if on ESA therapy PTH, Ca, P. q 3-6 mo. salt, phos. & potassium Anemia Vascular access placement Modality options REFERRALS Surgeon for vascular access placement Transplant center for eval GFR q 1-3 mo. Hgb monthly PTH, Ca, P q 1-3 mo. HBV titer fluids, salt, phos. & potassium Anemia Vascular access monitoring Modality options Evaluation for kidney transplant REFERRALS Surgeon for vascular access intervention, as needed Transplant center for eval
The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009
The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 Teresa Northcutt, RN BSN Primaris Program Manager, Prevention - CKD MO-09-01-CKD This material was prepared by Primaris,
CKDinform: A PCP s Guide to CKD Detection and Delaying Progression
CKDinform: A PCP s Guide to CKD Detection and Delaying Progression Learning Objectives Describe suitable screening tools, such as GFR and ACR, for proper utilization in clinical practice related to the
Chronic Kidney Disease
Chronic Kidney Disease Chronic Kidney Disease (CKD) Educational Objectives Outline Demographics Propose Strategies to slow progression and improve outcomes Plan for treatment of CKD Chronic Kidney Disease
Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives
The Role of the Primary Physician and the Nephrologist in the Management of Chronic Kidney Disease () By Brian Young, M.D. Assistant Clinical Professor of Medicine David Geffen School of Medicine at UCLA
QUICK REFERENCE FOR HEALTHCARE PROVIDERS
KEY MESSAGES 1 SCREENING CRITERIA Screen: Patients with DM and/or hypertension at least yearly. Consider screening patients with: Age >65 years old Family history of stage 5 CKD or hereditary kidney disease
Concept and General Objectives of the Conference: Prognosis Matters. Andrew S. Levey, MD Tufts Medical Center Boston, MA
Concept and General Objectives of the Conference: Prognosis Matters Andrew S. Levey, MD Tufts Medical Center Boston, MA General Objectives Topics to discuss What are the key outcomes of CKD? What progress
Chronic Kidney Disease
Chronic Kidney Disease Presence of kidney damage or decreased kidney function for three or more months, - necessary to distinguish CKD from acute kidney disease. Ascertained either by kidney biopsy or
Irish Practice Nurses Association Annual Conference Tullamore Court Hotel OCTOBER 6 th 2012
Irish Practice Nurses Association Annual Conference Tullamore Court Hotel OCTOBER 6 th 2012 Susan McKenna Renal Clinical Nurse Specialist Cavan General Hospital Renal patient population ACUTE RENAL FAILURE
Stages of Chronic Kidney Disease (CKD)
Early Treatment is the Key Stages of Chronic Kidney Disease (CKD) Stage Description GFR (ml/min/1.73 m 2 ) >90 1 Kidney damage with normal or GFR 2 Mild decrease in GFR 60-89 3 Moderate decrease in GFR
TREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009
TREAT THE KIDNEY TO SAVE THE HEART Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009 1 ESRD Prevalent Rates in 1996 per million population December
Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC
Elevation of Serum Creatinine: When to Screen, When to Refer Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC Presented at the University of Calgary s CME and Professional Development 2006-2007
VA/DoD Clinical Practice Guideline for the Management of Chronic Kidney Disease in Primary Care (2008) PROVIDER REFERENCE CARDS Chronic Kidney Disease
VA/DoD Clinical Practice Guideline for the Management of Chronic Kidney Disease in Primary Care (2008) PROVIDER REFERECE CARDS Chronic Kidney Disease CKD VA/DoD Clinical Practice Guideline for the Management
Chronic kidney disease : The role of the Pharmacist
Chronic kidney disease : The role of the Pharmacist Dr. Alladin-Karan (MBBS) Kidney Foundation of Guyana (KFG) Caribbean Association of Pharmacists Annual Convention Guyana Marriott Hotel 13 th August
Section Questions Answers
Section Questions Answers Guide to CKD Screening and Evaluation -Alec Otteman, MD Delaying Progression - Paul Drawz, MD, MHS, MS 1. Modifiable risk factors for CKD include: a. Diabetes b. Hypertension
Screening and early recognition of CKD. John Ngigi (FISN) Kidney specialist
Screening and early recognition of CKD John Ngigi (FISN) Kidney specialist screening Why? Who? When? How? Primary diagnosis for patients who start dialysis Other 10% Glomerulonephritis 13% No. of dialysis
Acknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD
A Practical Approach to Chronic Kidney Disease Management for the Primary Care Practioner: A web-site sponsored by the National Kidney Foundation of Connecticut Robert Reilly, M.D. Acknowledgements National
Outpatient Management of Chronic Kidney Disease for the Internist
Outpatient Management of Chronic Kidney Disease for the Internist Annual Meeting of Maryland Chapter of the American College of Physicians February 3, 2018 MARY (TESSIE) BEHRENS, MD, FACP, FASN, FNKF MID-ATLANTIC
Chronic Kidney Disease: Optimal and Coordinated Management
Chronic Kidney Disease: Optimal and Coordinated Management Michael Copland, MD, FRCPC Presented at University of British Columbia s 42nd Annual Post Graduate Review in Family Medicine Conference, Vancouver,
Applying clinical guidelines treating and managing CKD
Applying clinical guidelines treating and managing CKD Develop patient treatment plan according to level of severity. Source: Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012
Primary Care Approach to Management of CKD
Primary Care Approach to Management of CKD This PowerPoint was developed through a collaboration between the National Kidney Foundation and ASCP. Copyright 2018 National Kidney Foundation and ASCP Low
CKD FOR INTERNISTS. Dr Ahmed Hossain Associate professor Medicine Sir Salimullah Medical College
CKD FOR INTERNISTS Dr Ahmed Hossain Associate professor Medicine Sir Salimullah Medical College INTRODUCTION In 2002, the National Kidney Foundation s Kidney Disease Outcomes Quality Initiative(KDOQI)
Case #1. Current Management Strategies in Chronic Kidney Disease. Serum creatinine cont. Pitfalls of Serum Cr
Current Management Strategies in Chronic Kidney Disease Grace Lin, MD Assistant Professor of Medicine, University of California San Francisco Case #1 50 y.o. 70 kg man with long-standing hypertension is
Chronic kidney disease-what can you do and when to refer?
Chronic kidney disease-what can you do and when to refer? Dr Goh Heong Keong www.passpaces.com/kidney.htm Outline of Lecture Introduction Epidemiology of CKD in Malaysia/ World Complications of CKD What
Diabetic Kidney Disease in the Primary Care Clinic
Diabetic Kidney Disease in the Primary Care Clinic Jess Wheeler, DO Nephrology 2015 Outline: 1. CKD/DKD is a growing problem 2. Diagnosis of Chronic Kidney Disease (CKD) 3. Diagnosis of Diabetic Kidney
Professor Suetonia Palmer
Professor Suetonia Palmer Department of Medicine Nephrologist Christchurch Hospital Christchurch 14:00-14:55 WS #108: The Kidney Test - When To Test and When to Refer ( and When Not To) 15:05-16:00 WS
CKD IN THE CLINIC. Session Content. Recommendations for commonly used medications in CKD. CKD screening and referral
CKD IN THE CLINIC Family Physician Refresher Course Lisa M. Antes, MD April 19, 2017 No disclosures Session Content 1. 2. Recommendations for commonly used medications in CKD Basic principles /patient
8 th Annual Congress of the Bangladesh Society of Medicine Dhaka, Bangladesh March 23-24, Jeffrey P. Harris MD, FACP
8 th Annual Congress of the Bangladesh Society of Medicine Dhaka, Bangladesh March 23-24, 2008 The Internist and the Pre-End Stage Renal Disease Patient Jeffrey P. Harris MD, FACP Country: Bangladesh Population:
SAMPLE. Chronic Kidney Disease, Evidence-Based Practice, and the Nutrition Care Process. Chapter 1
Chapter 1 Chronic Kidney Disease, Evidence-Based Practice, and the Nutrition Care Process This guide follows the steps of the Nutrition Care Process (NCP) nutrition assessment, nutrition diagnosis, nutrition
Special Challenges and Co-Morbidities
Special Challenges and Co-Morbidities Renal Disease/ Hypertension/ Diabetes in African-Americans M. Keith Rawlings, MD Medical Director Peabody Health Center AIDS Arms, Inc Dallas, TX Chair, Internal Medicine
Long-Term Care Updates
Long-Term Care Updates January 2016 By Yunuo (Enora) Wu, PharmD Chronic kidney disease (CKD) is defined as kidney damage (including structural or functional abnormalities) or glomerular filtration rate
PRE-DIALYSIS CARE IN CHRONIC KIDNEY DISEASE PATIENTS DR O. A ADEJUMO MBBS, FWACP, FMCP
PRE-DIALYSIS CARE IN CHRONIC KIDNEY DISEASE PATIENTS DR O. A ADEJUMO MBBS, FWACP, FMCP OUTLINE INTRODUCTION BURDEN OF CKD DEFINITION OF PRE-DIALYSIS CARE (PDC) GOALS OF PDC IN CKD COMPONENTS OF PDC ADVANTAGES
DIABETES AND CHRONIC KIDNEY DISEASE
DIABETES AND CHRONIC KIDNEY DISEASE Stages 1 4 www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney Foundation's Kidney Disease Outcomes
Transforming Diabetes Care
Transforming Diabetes Care Diabetic Kidney Disease: Prevention, Detection and Treatment Alexis Chettiar, ACNP-BC, PhD(c) 1 Polling Question - 1 What is your role as a healthcare provider? a) Dietitian
Kidney Disease. Chronic kidney disease (CKD) requiring dialysis. The F.P. s Role in the Management of Chronic. Stages
Focus on CME at McMaster University The F.P. s Role in the Management of Chronic Kidney Disease By David N. Churchill, MD, FRCPC, FACP Presented at McMaster University CME Half-Day in Nephrology for Family
CHRONIC RENAL FAILURE: WHAT THE PRIMARY CARE CAN OFFER. The annual conference of the Lebanese Society of Family Medicine October 2017 Dr Hiba AZAR
CHRONIC RENAL FAILURE: WHAT THE PRIMARY CARE CAN OFFER The annual conference of the Lebanese Society of Family Medicine October 2017 Dr Hiba AZAR OUTLINE: A journey through CKD Screening for CKD: The why,
Office Management of Reduced GFR Practical advice for the management of CKD
Office Management of Reduced GFR Practical advice for the management of CKD CKD Online Education CME for Primary Care April 27, 2016 Monica Beaulieu, MD FRCPC MHA CHAIR PROVINCIAL KIDNEY CARE COMMITTEE
Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York
Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York 4th International Conference on Nephrology & Therapeutics September 14, 2015 Baltimore,
Chronic Kidney Disease - An Overview
REVIEW ARTICLE KERALA MEDICAL JOURNAL Chronic Kidney Disease - An Overview Rajesh R Nair Department of Nephrology, Amrita Institute of Medical Sciences, Kochi, Kerala* ABSTRACT Published on 28 th December
CONCORD INTERNAL MEDICINE CHRONIC KIDNEY DISEASE PROTOCOL. Revised May 30, 2012
CONCORD INTERNAL MEDICINE CHRONIC KIDNEY DISEASE PROTOCOL Douglas G. Kelling, Jr., MD C. Gismondi-Eagan, MD, FACP George C. Monroe III, MD Revised May 30, 2012 The information contained in this protocol
Management of Early Kidney Disease: What to do Before Referring to the Nephrologist
Management of Early Kidney Disease: What to do Before Referring to the Nephrologist Andrew S. Narva, MD, NIDDK Saturday, February 18, 2017 8:45 a.m. 9:30 a.m. Although evidence-based guidelines for managing
ARE YOU AT INCREASED RISK FOR CHRONIC KIDNEY DISEASE?
ARE YOU AT INCREASED RISK FOR CHRONIC KIDNEY DISEASE? www.kidney.org National Kidney Foundation s Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney Foundation s Kidney Disease
Agroup of clinicians, researchers, ... REPORT... Chronic Kidney Disease: Stating the Managed Care Case for Early Treatment
... REPORT... Chronic Kidney Disease: Stating the Managed Care Case for Early Treatment Discussion and Consensus of Presentations of Economic Analyses, Managed Care Organization Case Studies, and Opportunities
Nice CKD Clinical Guidelines 2014 The challenges and benefits they may bring toprimary care
Nice CKD Clinical Guidelines 2014 The challenges and benefits they may bring toprimary care Paula D Souza Senior CKD Nurse Specialist Royal Devon and Exeter Healthcare Trust Introduction Background What
What should you do next? Presenter Disclosure Information. Learning Objectives. Case: George
2:45 3:45pm Optimizing the Management of Patients with Chronic Kidney Disease SPEAKER Jay B. Wish, MD, FACP Presenter Disclosure Information The following relationships exist related to this presentation:
Identifying and Managing Chronic Kidney Disease: A Practical Approach
Identifying and Managing Chronic Kidney Disease: A Practical Approach S. Neil Finkle, MD, FRCPC Associate Professor Division of Nephrology, Department of Medicine, Dalhousie University Program Director,
Chronic Kidney Disease Clinical Practice Guidelines: Implementation Strategies
Chronic Kidney Disease Clinical Practice Guidelines: Implementation Strategies Guidelines International Network November 2, 2004 The National Kidney Foundation The Mission of the National Kidney Foundation
Chapter Five Clinical indicators & preventive health
Chapter Five Clinical indicators & preventive health The painter who draws merely by practice and by eye, without any reason, is like a mirror which copies every thing placed in front of it without being
Chronic Kidney Disease
Chronic Kidney Disease Chronic Kidney Disease (CKD) Guideline (2010) Chronic Kidney Disease CKD: Executive Summary of Recommendations (2010) Executive Summary of Recommendations Below are the major recommendations
Chronic Kidney Disease. Basics of CKD Terms Diagnosis Management
Chronic Kidney Disease Basics of CKD Terms Diagnosis Management Review the prevalence of chronic kidney disease (CKD) Review how CKD develops Review populations at risk for CKD Review CKD diagnosis Objectives
QUALITY OF LIFE WITH DIABETES AND CHRONIC KIDNEY DISEASE
QUALITY OF LIFE WITH DIABETES AND CHRONIC KIDNEY DISEASE www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney Foundation's Kidney
Renal Replacement Therapy - Indication and Follow up
Renal Replacement Therapy - Indication and Follow up Prof Brigadier General Mamun Mostafi FCPS, FRCP Chief Physician Combined Military Hospital Dhaka Bangladesh Primary Functions of the Kidney Removal
KEEP 2.0 Annual Data Report Chapter Five
KEEP 2. Annual Data Report Chapter Five Figure 5.1 percent distribution of KEEP participants with elevated serum creatinine levels, overall & by age 16 Percent of participants 12 8 4 All
Classification of CKD by Diagnosis
Classification of CKD by Diagnosis Diabetic Kidney Disease Glomerular diseases (autoimmune diseases, systemic infections, drugs, neoplasia) Vascular diseases (renal artery disease, hypertension, microangiopathy)
Guest Speaker Evaluations Viewer Call-In Thanks to our Sponsors: Phone: Fax: Public Health Live T 2 B 2
Public Health Live T 2 B 2 Chronic Kidney Disease in Diabetes: Early Identification and Intervention Guest Speaker Joseph Vassalotti, MD, FASN Chief Medical Officer National Kidney Foundation Thanks to
Addressing Chronic Kidney Disease in People with Multiple Chronic Conditions
Addressing Chronic Kidney Disease in People with Multiple Chronic Conditions Andrew S Narva, MD Na/onal Kidney Disease Educa/on Program U.S. Department of Health and Human Services National Institute of
Lesson #7: Quality Assessment and Performance Improvement
ESRD Update: Transitioning to New ESRD Conditions for Coverage Student Manual Lesson #7: Quality Assessment and Performance Improvement Learning Objectives At the conclusion of this lesson, you will be
RENAL FAILURE IN CHILDREN Dr. Mai Mohamed Elhassan Assistant Professor Jazan University
RENAL FAILURE IN CHILDREN Dr. Mai Mohamed Elhassan Assistant Professor Jazan University OBJECTIVES By the end of this lecture each student should be able to: Define acute & chronic kidney disease(ckd)
Chronic Kidney Disease (CKD) and egfr: Decision and Dilemma. Dr Bhavna K Pandya Consultant Nephrologist University Hospital Aintree
Chronic Kidney Disease (CKD) and egfr: Decision and Dilemma Dr Bhavna K Pandya Consultant Nephrologist University Hospital Aintree Topics CKD background egfr background Patient with egfr Referral Guidelines
Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD?
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
www.usrds.org www.usrds.org 1 1,749 + (2,032) 1,563 to TRANSLATE CKD Academic Mentoring Intervention Practices. Chester Fox, MD Joseph Vassalotti, MD
TRANSLATE CKD Academic Mentoring Intervention Practices Chester Fox, MD Joseph Vassalotti, MD Outline Key Evidence Based Points KDOQI Guidelines with Strong Consensus Base Study Outcome Measures Key Tools
Chronic Kidney Disease The 6 Pillars. Dr. Tiina Podymow Associate Professor Division of Nephrology McGill University Health Centre
Chronic Kidney Disease The 6 Pillars Dr. Tiina Podymow Associate Professor Division of Nephrology McGill University Health Centre None Disclosures Objectives 1. Describe evidence-based measures to slow
DIABETES AND YOUR KIDNEYS
DIABETES AND YOUR KIDNEYS OR AS WE CALL IT DIABETIC NEPHROPATHY The latest guidelines to keep you safe, healthy, fit, and out of danger from needing dialysis A UCLA HEALTH EDUCATIONAL SEMINAR Ramy M. Hanna
transplant Professional Education
Professional Education Although successful kidney transplants may provide a better quality of life than dialysis, transplant recipients may still have CKD. best practices in Managing adverse events related
Update on HIV-Related Kidney Diseases. Agenda
Update on HIV-Related Kidney Diseases ANDY CHOI THE MEDICAL MANAGEMENT OF HIV/AIDS DECEMBER 15, 2006 Agenda 1. EPIDEMIOLOGY: A) END STAGE RENAL DISEASE (ESRD) B) CHRONIC KIDNEY DISEASE (CKD) 2. HIV-ASSOCIATED
CKD and risk management : NICE guideline
CKD and risk management : NICE guideline 2008-2014 Shahed Ahmed Consultant Nephrologist shahed.ahmed@rlbuht.nhs.uk Key points : Changing parameters of CKD and NICE guidance CKD and age related change of
MANAGERIAL. Potential Application of the National Kidney Foundation s Chronic Kidney Disease Guidelines in a Managed Care Setting
Potential Application of the National Kidney Foundation s Chronic Kidney Disease Guidelines in a Managed Care Setting Micah L. Thorp, DO, MPH; and Loris Eastman, RN, CNN Chronic kidney disease (CKD) is
Kidney Disease, Hypertension and Cardiovascular Risk
1 Kidney Disease, Hypertension and Cardiovascular Risk George Bakris, MD, FAHA, FASN Professor of Medicine Director, Hypertensive Diseases Unit The University of Chicago-Pritzker School of Medicine Chicago,
Department of Nephrology
OUTCOMES DIVISION OF MEDICINE Department of Nephrology About Cleveland Clinic Florida Cleveland Clinic Florida s medical staff are dedicated physicians who have joined the clinic as salaried doctors to
HIV AND CHRONIC KIDNEY DISEASE. Understanding GFR
HIV AND CHRONIC KIDNEY DISEASE Understanding GFR in PEOPLE WITH HIV contents Introduction... 4 Chronic Kidney Disease... 5 What are kidneys and what do they do?... 5 What is glomerular filtration rate
Outline. Outline 10/14/2014 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
S150 KEEP Analytical Methods. American Journal of Kidney Diseases, Vol 55, No 3, Suppl 2, 2010:pp S150-S153
S150 KEEP 2009 Analytical Methods American Journal of Kidney Diseases, Vol 55, No 3, Suppl 2, 2010:pp S150-S153 S151 The Kidney Early Evaluation program (KEEP) is a free, communitybased health screening
Guidelines for the psychological management of chronic kidney disease patients (for the Psychologist)
Indian J Nephrol 2005;15, Supplement 1: S103-S108 S 103 Guidelines for the psychological management of chronic kidney disease patients (for the Psychologist) Introduction With increasing levels of sophistication
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic kidney disease: early identification and management of adults with chronic kidney disease in primary and secondary
Swindon Diabetes Guidelines: Management of Chronic Kidney Disease Associated with Diabetes Mellitus
Swindon Diabetes Guidelines: Management of Chronic Kidney Disease Associated with Diabetes Mellitus 1 Contents Executive Summary... 3 How to Screen for Diabetic Nephropathy... 4 What to Measure... 4 Frequency
Objectives. Kidney Complications With Diabetes. Case 10/21/2015
Objectives Kidney Complications With Diabetes Brian Boerner, MD Diabetes, Endocrinology, and Metabolism University of Nebraska Medical Center Review screening for, and management of, albuminuria Review
Outline. Outline. Introduction CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 8/11/2011
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
The National Quality Standards for Chronic Kidney Disease
The National Quality Standards for Chronic Kidney Disease Dr Robert Lewis Chief of Service, Wessex Kidney Centre, Portsmouth Specialist Committee Member Quality Standard for Chronic Kidney Disease, NICE
The future is here. It s just not widely distributed yet. William Gibson
The future is here. It s just not widely distributed yet. William Gibson CHRONIC KIDNEY DISEASE MANAGEMENT A NEW PARADIGM Aaron Cass, MD, FRCPC Nephrologist, Fraser Health January 22, 2014 Where Are We
Taking Care of Your Kidneys
Taking Care of Your Kidneys Part A Roseville & Sacramento Medical Centers Health Promotion Department Nutritional Services Agenda Slide How your kidneys work Explaining chronic kidney disease Protecting
Chapter 2 Chronic Kidney Disease (CKD) in Cancer Patients
Chapter 2 Chronic Kidney Disease (CKD) in Cancer Patients Mala Sachdeva, Amit Lahoti and Anna Mathew List of Abbreviations ACE Angiotensin converting enzyme AKI Acute kidney injury ARB Angiotensin II receptor
KEEP 2009 Summary Figures
S4 29 Summary Figures American Journal of Kidney Diseases, Vol 55, No 3, Suppl 2, 21:pp S4-S57 S41 Definitions DATA ANALYSES DIABETES Self-reported diabetes, self reported diabetic retinopathy, receiving
Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
Information for patients with kidney disease attending the Low Clearance Clinic
Information for patients with kidney disease attending the Low Clearance Clinic Why am I attending this Clinic? Your kidneys are not working effectively. This means they cannot do their usual jobs such
Outline. Introduction. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 6/26/2012
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
Thanks to our Speaker!
Thanks to our Speaker! Poyyapakkam R. Srivaths, MD, MS Medical Director of Pheresis Services Pediatric Renal Section at Texas Children s Hospital Texas Children s Hospital - Houston, Texas Chronic Kidney
A n aly tical m e t h o d s
a A n aly tical m e t h o d s If I didn t go to the screening at Farmers Market I would not have known about my kidney problems. I am grateful to the whole staff. They were very professional. Thank you.
Understanding. Your Kidneys. Laurie Biel, RN,BSN, CNN The MGH Center For Renal Education March 28, 2016
Understanding Your Kidneys Laurie Biel, RN,BSN, CNN The MGH Center For Renal Education March 28, 2016 Today s Discussion - The Role of your kidneys Common causes of kidney disease Treatment for kidney
The biologic price of aging includes progressive
The Aging Kidney: Physiological Changes The biologic price of aging includes progressive structural and functional deterioration of the kidney, and these changes are among the most dramatic of any organ
CHRONIC KIDNEY DISEASE (CKD)
CHRONIC KIDNEY DISEASE (CKD) CKD implies longstanding (more than 3 months), and usually progressive, impairment in renal function. In many instances, no effective means are available to reverse the primary
Analytical Methods: the Kidney Early Evaluation Program (KEEP) The Kidney Early Evaluation program (KEEP) is a free, community based health
Analytical Methods: the Kidney Early Evaluation Program (KEEP) 2000 2006 Database Design and Study Participants The Kidney Early Evaluation program (KEEP) is a free, community based health screening program
Session 9: Optimizing the Management of Patients with Chronic Kidney Disease Learning Objectives
Session 9: Optimizing the Management of Patients with Chronic Kidney Disease Learning Objectives 1. Understand the impact of chronic kidney disease (CKD) as a common condition of the adult US population.
Quality ID #119 (NQF 0062): Diabetes: Medical Attention for Nephropathy National Quality Strategy Domain: Effective Clinical Care
Quality ID #119 (NQF 0062): Diabetes: Medical Attention for Nephropathy National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process
OUTLINE INTRODUCTION EPIDEMIOLOGY CLASSIFICATION DIAGNOSIS AETIOLOGY MANAGEMENT FINANCIAL BURDEN OF ESRD SCREENIG GUIDELINE CONCLUSION
Dr O. A ADEJUMO OUTLINE INTRODUCTION EPIDEMIOLOGY CLASSIFICATION DIAGNOSIS AETIOLOGY MANAGEMENT FINANCIAL BURDEN OF ESRD SCREENIG GUIDELINE CONCLUSION Introduction Chronic Kidney Disease is defined as
Chronic Kidney Disease for the Primary Care Physician in What do the Kidneys do? CKD in the US
1:25-2:25pm Managing Chronic Kidney Disease in 2019 SPEAKERS Adriana Dejman, MD Chronic Kidney Disease for the Primary Care Physician in 2019 Adriana Dejman, MD Assistant Professor of Clinical Medicine
Diabetes in Renal Patients. Contents. Understanding Diabetic Nephropathy
Diabetes in Renal Patients Contents Understanding Diabetic Nephropathy What effect does CKD have on a patient s diabetic control? Diabetic Drugs in CKD and Dialysis Patients Hyper and Hypoglycaemia in
Predicting and changing the future for people with CKD
Predicting and changing the future for people with CKD I. David Weiner, M.D. Co-holder, C. Craig and Audrae Tisher Chair in Nephrology Professor of Medicine and Physiology and Functional Genomics University
HYPERTENSION IN CKD. LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL
HYPERTENSION IN CKD LEENA ONGAJYOOTH, M.D., Dr.med RENAL UNIT SIRIRAJ HOSPITAL Stages in Progression of Chronic Kidney Disease and Therapeutic Strategies Complications Normal Increased risk Damage GFR
Educational Goals & Objectives
Educational Goals & Objectives The nephrology rotation will provide the resident with an opportunity to evaluate and manage patients across the spectrum of renal disorders in both the inpatient and outpatient
CARE FOR CHRONIC RENAL PATIENTS ROLE OF MULTIDISCIPLINARY APPROACH ÁGNES HARIS MD PHD, ST. MARGIT HOSPITAL, BUDAPEST BUDAPEST NEPHROLOGY SCHOOL, 2017
CARE FOR CHRONIC RENAL PATIENTS ROLE OF MULTIDISCIPLINARY APPROACH ÁGNES HARIS MD PHD, ST. MARGIT HOSPITAL, BUDAPEST BUDAPEST NEPHROLOGY SCHOOL, 2017 RENEGOTIATING LIFE WITH CHRONIC KIDNEY DISEASE CONSTANTINI